Loading company…
Nerai Bio develops genetic medicines using protein engineering and artificial intelligence.
Nerai Bio develops genetic medicine using protein engineering and artificial intelligence. Its Morpheme platform supports protein engineering for genome editing, and its first two therapeutic candidates target monogenic liver disorders. The company is based in Zurich, Switzerland, and was founded by Vincent Forster, Sasha Melkonyan, Lukas Schmidheini, Kim Marquart, and Gerald Schwank. Venture Kick provided CHF 0.15 million in November 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in